UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 225

Sortiert nach

Selectivity of HIF-PH inhibitors: concerns regarding possible off-target effects

Clinical and experimental nephrology, 2021-09, Vol.25 (9), p.1047-1048

Nagano, Nobuo

2021

Volltextzugriff (PDF)

Fibroblast Growth Factor 23/Klotho Axis in Chronic Kidney Disease

Nephron, 2014-12, Vol.128 (1-2), p.1-10

2014

Volltextzugriff (PDF)

Impact of phosphate binders on medication dosing frequency, timing, and number of prescribed pills in hemodialysis patients

Therapeutic apheresis and dialysis, 2022-12, Vol.26 (6), p.1174-1181

2022

Volltextzugriff (PDF)

Serum oxalate concentration is associated with coronary artery calcification and cardiovascular events in Japanese dialysis patients

Scientific reports, 2023-10, Vol.13 (1), p.18558-18558, Article 18558

2023

Volltextzugriff (PDF)

Fibroblast growth factor 23 is upregulated in the kidney in a chronic kidney disease rat model

PloS one, 2018-03, Vol.13 (3), p.e0191706-e0191706

2018

Volltextzugriff (PDF)

Effect of Polydextrose Intake on Constipation in Japanese Dialysis Patients: A Triple-Blind, Randomized, Controlled Trial

Journal of Nutritional Science and Vitaminology, 2015, Vol.61(4), pp.345-353

2015

Volltextzugriff (PDF)

Long-term treatment of evocalcet in hemodialysis patients with secondary hyperparathyroidism: a five-year prospective cohort study in 147 Japanese patients

Renal replacement therapy, 2024-03, Vol.10 (1), p.13-7, Article 13

2024

Volltextzugriff (PDF)

Drug discovery related to zinc

Folia Pharmacologica Japonica, 2023, Vol.158(1), pp.101-101

Nagano, Nobuo

2023

Volltextzugriff (PDF)

Drug discovery related to zinc

Nihon yakurigaku zasshi, 2023, Vol.158 (1), p.101-101, Article 22066

Nagano, Nobuo

2023

Volltextzugriff (PDF)

Prescription characteristics of phosphate binders in a high pill burden for hemodialysis patients

Renal replacement therapy, 2021-02, Vol.7 (1), p.5-11, Article 5

2021

Volltextzugriff (PDF)

Phosphate Binders Derived from Natural Ores Contain Many Kinds of Metallic Elements Besides Their Active Ingredient Metals

Therapeutic apheresis and dialysis, 2018-12, Vol.22 (6), p.630-634

2018

Volltextzugriff (PDF)

Impact of the Visceral Fat Area Measured by Dual Impedance Method on the Diagnostic Components of Metabolic Diseases in a Middle-aged Japanese Population

Internal Medicine, 2016/07/01, Vol.55(13), pp.1691-1696

2016

Volltextzugriff (PDF)

Pathogenesis of secondary hyperparathyroidism and fibroblast growth factor 23: a pharmacological validation of the "trade-off hypothesis"

American journal of physiology: endocrinology and metabolism, 2012-06, Vol.302 (11), p.E1450-E1451

2012

Volltextzugriff (PDF)

Pharmacological and clinical properties of calcimimetics: calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism

Pharmacology & therapeutics (Oxford), 2006-03, Vol.109 (3), p.339-365

Nagano, Nobuo

2006

Volltextzugriff (PDF)

2696 The effect of laxatives on reducing serum phosphate levels of probiotics in hemodialysis patients: a subanalysis of RCT

Nephrology, dialysis, transplantation, 2024-05, Vol.39 (Supplement_1)

2024

Volltextzugriff (PDF)

Functional Proteins Involved in Regulation of Intracellular Ca2+ for Drug Development: The Extracellular Calcium Receptor and an Innovative Medical Approach to Control Secondary Hyperparathyroidism by Calcimimetics

Journal of Pharmacological Sciences, 2005, Vol.97(3), pp.355-360

2005

Volltextzugriff (PDF)

Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease

Kidney international, 2010-11, Vol.78 (10), p.975-980

2010

Volltextzugriff (PDF)

Activation of the calcium receptor by a calcimimetic compound halts the progression of secondary hyperparathyroidism in uremic rats

Journal of the American Society of Nephrology, 2000-05, Vol.11 (5), p.903-911

2000

Volltextzugriff (PDF)

Relationship between parathyroid calcium-sensing receptor expression and potency of the calcimimetic, cinacalcet, in suppressing parathyroid hormone secretion in an in vivo murine model of primary hyperparathyroidism

European journal of endocrinology, 2005-10, Vol.153 (4), p.587

2005

Volltextzugriff (PDF)

SO055PROBIOTIC BIO-THREE DECREASES SERUM PHOSPHATE LEVELS WITH INVOLVEMENT OF BACTERIA IN GUT MICROBIOMA IN HEMODIALYSIS PATIENTS: A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTOLLED STUDY

Nephrology, dialysis, transplantation, 2020-06, Vol.35 (Supplement_3)

2020

Volltextzugriff (PDF)

Pharmacological characteristics of drugs targeted on calcium-sensing receptor.-properties of cinacalcet hydrochloride as allosteric modulator

Clinical calcium, 2016-06, Vol.26 (6), p.839

2016

Volltextzugriff (PDF)

Association between phosphate binder pill burden and mortality risk in patients on maintenance hemodialysis: a single-center cohort study with 7-year follow-up of 513 patients

Clinical and experimental nephrology, 2023-11, Vol.27 (11), p.961-971

2023

Volltextzugriff (PDF)

Cinacalcet suppresses calcification of the aorta and heart in uremic rats

Kidney international, 2008-11, Vol.74 (10), p.1270-1277

2008

Volltextzugriff (PDF)

SP319RELATIONSHIP OF VISCERAL AND SUBCUTANEOUS FAT WITH THE DECREASE OF RENAL FUNCTION FOR SEVEN YEARS IN PEOPLE WITH OBESITY

Nephrology, dialysis, transplantation, 2015-05, Vol.30 (suppl_3), p.iii484-iii485

2015

Volltextzugriff (PDF)

Comparison of serum alkaline phosphatase levels between two measurement methods in chronic hemodialysis patients in Japan: involvement of ABO blood group system and relationship with mortality risk

Clinical and experimental nephrology, 2024-08

2024

Volltextzugriff (PDF)

1 – 25 von 225

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(166)
Mit Volltextzugriff
(200)

Publikationsform

Sprache

Englisch
(177)
Japanisch
(108)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Selectivity of HIF-PH inhibitors: concerns regarding possible off-target effects

Fibroblast Growth Factor 23/Klotho Axis in Chronic Kidney Disease

Impact of phosphate binders on medication dosing frequency, timing, and number of prescribed pills in hemodialysis patients

Serum oxalate concentration is associated with coronary artery calcification and cardiovascular events in Japanese dialysis patients

Fibroblast growth factor 23 is upregulated in the kidney in a chronic kidney disease rat model

Effect of Polydextrose Intake on Constipation in Japanese Dialysis Patients: A Triple-Blind, Randomized, Controlled Trial

Long-term treatment of evocalcet in hemodialysis patients with secondary hyperparathyroidism: a five-year prospective cohort study in 147 Japanese patients

Drug discovery related to zinc

Drug discovery related to zinc

Prescription characteristics of phosphate binders in a high pill burden for hemodialysis patients

Phosphate Binders Derived from Natural Ores Contain Many Kinds of Metallic Elements Besides Their Active Ingredient Metals

Impact of the Visceral Fat Area Measured by Dual Impedance Method on the Diagnostic Components of Metabolic Diseases in a Middle-aged Japanese Population

Pathogenesis of secondary hyperparathyroidism and fibroblast growth factor 23: a pharmacological validation of the "trade-off hypothesis"

Pharmacological and clinical properties of calcimimetics: calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism

2696 The effect of laxatives on reducing serum phosphate levels of probiotics in hemodialysis patients: a subanalysis of RCT

Functional Proteins Involved in Regulation of Intracellular Ca2+ for Drug Development: The Extracellular Calcium Receptor and an Innovative Medical Approach to Control Secondary Hyperparathyroidism by Calcimimetics

Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease

Activation of the calcium receptor by a calcimimetic compound halts the progression of secondary hyperparathyroidism in uremic rats

Relationship between parathyroid calcium-sensing receptor expression and potency of the calcimimetic, cinacalcet, in suppressing parathyroid hormone secretion in an in vivo murine model of primary hyperparathyroidism

SO055PROBIOTIC BIO-THREE DECREASES SERUM PHOSPHATE LEVELS WITH INVOLVEMENT OF BACTERIA IN GUT MICROBIOMA IN HEMODIALYSIS PATIENTS: A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTOLLED STUDY

Pharmacological characteristics of drugs targeted on calcium-sensing receptor.-properties of cinacalcet hydrochloride as allosteric modulator

Association between phosphate binder pill burden and mortality risk in patients on maintenance hemodialysis: a single-center cohort study with 7-year follow-up of 513 patients

Cinacalcet suppresses calcification of the aorta and heart in uremic rats

SP319RELATIONSHIP OF VISCERAL AND SUBCUTANEOUS FAT WITH THE DECREASE OF RENAL FUNCTION FOR SEVEN YEARS IN PEOPLE WITH OBESITY

Comparison of serum alkaline phosphatase levels between two measurement methods in chronic hemodialysis patients in Japan: involvement of ABO blood group system and relationship with mortality risk

Suchergebnisse filtern